AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI

by Ysios Capital

€23m has been mainly provided by Cowen Healthcare Investments, an affiliate of Cowen Inc., which joins the existing investor syndicate of LSP and Andera Partners, Forbion, Ysios Capital, Kurma Partn...

Read more

AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury

by Ysios Capital

Financing co-led by new investors LSP and Andera Partners, with participation of existing investors Forbion, Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthca...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Grupo ONEtoONE desembarca con su fondo d...

by ONEtoONE Corporate Finance

ONEtoONE Asset Management ha realizado su quinta inversión fuera de n...

Photos Stream